Zelenirstat

The journey towards a breakthrough cancer treatment often begins with groundbreaking trials. Zelenirstat is a cutting-edge drug currently under study. It has shown promise in its first-ever trial involving mesothelioma patients. These are significant first steps in paving the way for potential new treatments. A First-In-Human Trial Scientists are exploring a new treatment, Zelenirstat for tough cancers like mesothelioma. They tested this treatment on 21 patients with various cancers. This was in a special trial called a “first-in-human” trial. They gave different doses of Zelenirstat, starting from 20 mg to 280 mg every day, to see if it could help. A “first-in-human” trial refers to the initial stage of testing a new drug or treatment in people. Before any medication…